A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox
Clinical trial NCT05740982 · COMPLETED
Trial details
- NCT number
- NCT05740982
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-22
- Primary completion
- 2024-08-28
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.